Atlas Trials

Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects

Clinical trial NCT02154360 · COMPLETED

Trial details

NCT number
NCT02154360
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infection
Start date
2014-05-01
Primary completion
2015-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.